Cargando…
Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis
BACKGROUND: Stromal–tumour interactions facilitate pancreatic cancer (PC) progression. The hepatocyte growth factor (HGF)/c-MET pathway is upregulated in PC and mediates the interaction between cancer cells and stromal pancreatic stellate cells (PSCs). This study assessed the effect of HGF/c-MET inh...
Autores principales: | Xu, Zhihong, Pang, Tony C. Y., Liu, Adele C., Pothula, Srinivasa P., Mekapogu, Alpha Raj, Perera, Chamini J., Murakami, Takashi, Goldstein, David, Pirola, Romano C., Wilson, Jeremy S., Apte, Minoti V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217847/ https://www.ncbi.nlm.nih.gov/pubmed/32203220 http://dx.doi.org/10.1038/s41416-020-0782-1 |
Ejemplares similares
-
HGF/c-Met Inhibition as Adjuvant Therapy Improves Outcomes in an Orthotopic Mouse Model of Pancreatic Cancer
por: Pang, Tony C. Y., et al.
Publicado: (2021) -
Targeting HGF/c-MET Axis in Pancreatic Cancer
por: Pothula, Srinivasa P., et al.
Publicado: (2020) -
Reply letter to comments on: Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis
por: Xu, Zhihong, et al.
Publicado: (2020) -
Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer
por: Pothula, Srinivasa P., et al.
Publicado: (2017) -
Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)
por: Hosen, S. M. Zahid, et al.
Publicado: (2022)